MYT1

MYT1 encodes a CCHHC zinc-finger DNA-binding transcription factor expressed in neural progenitors and oligodendrocyte lineage cells, where it regulates proliferation, differentiation, and myelin gene transcription^[1]. Mechanistically, MYT1 family proteins recruit Sin3B-HDAC complexes and can repress neural transcription, linking MYT1 to chromatin-dependent control of neural differentiation^[2]. In neurogenesis models, MyT1 counteracts the neural progenitor program and promotes vertebrate neurogenesis downstream of proneural activity^[3]. In demyelination research, MYT1 expression increases in murine hepatitis virus-induced spinal cord lesions and appears in multiple sclerosis lesions, supporting its use in oligodendrocyte progenitor and remyelination study designs^[4]. Compared with related MYT1 family isoforms, MYT1 and MYT1L share transcriptional repressor activity, but MYT1L is more strongly associated with neuronal identity programs, whereas MYT1 has direct evidence in oligodendrocyte lineage progression^[1][5]. In glioblastoma models, re-expression of Myt1 or Myt1l reduces proliferation, activates neuronal differentiation programs, and represses YAP1 expression, providing an experimental framework for studying MYT1-family regulation of proliferation and differentiation^[6]. No specific MYT1 agonist or inhibitor is established in these cited studies.